Walgreens (WAG) reported May sales of $6.22 billion, an increase of 4.3 percent from $5.97 billion last year. Sales in comparable stores increased by 2.8 percent in May. The company said calendar day shifts negatively impacted total comparable sales by 0.3 percentage point, while generic drug introductions in the last 12 months negatively impacted total comparable sales by 2.3 percentage points.
Total front-end sales increased 3.4 percent, while comparable store front-end sales increased 1.2 percent.
May pharmacy sales increased by 4.4 percent, while comparable store pharmacy sales increased 3.8 percent and increased by a calendar day-shift adjusted 4.2 percent. Calendar day shifts negatively impacted pharmacy sales in comparable stores by 0.4 percentage point. Calendar day-shift adjusted comparable store pharmacy sales were negatively impacted by 3.7 percentage points due to generic drug introductions in the last 12 months. Pharmacy sales accounted for 63.1 percent of total sales for the month.
Total sales for the third quarter of fiscal 2013 were $18.34 billion, up 3.3 percent from $17.75 billion last year. Comparable store sales for the third quarter increased 1.3 percent, while front-end comparable store sales for the quarter increased 0.3 percent. Comparable pharmacy sales increased 2.0 percent.
For comments and feedback: editorial@rttnews.com